Skip to main content
Log in

Interaction between NMDA and CB2 function in the dorsal hippocampus on memory consolidation impairment: an isobologram analysis

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Convincing evidence has supported the pivotal role of N-methyl-d-aspartate receptors (NMDARs) and CB2Rs in the regulation of learning and memory.

Objective

In this study, the role of hippocampal (CA1 region) CB2 receptors on aversive memory consolidation deficit induced by D-AP5, a NMDA receptor antagonist, was evaluated.

Methods

Adult male Wistar rats received cannula implants that bilaterally targeted the CA1 region. Long-term memory was examined using the step-through type of passive avoidance task.

Results

Post-training, intra-CA1 microinjection of D-AP5 (0.5 and 0.75 μg/rat), GP1a (CB2 receptor agonist at dose of 150 ng/rat) and AM630 (CB2 receptor antagonist at doses 75 and 100 ng/rat) impaired memory consolidation processes. Intra-CA1 microinjection of a lower dose of GP1a or AM630 restored memory impairment induced by D-AP5 at the two higher doses, while AM630 decreased D-AP5 memory response at the lower dose. The isobologram analysis showed that there is a synergistic effect between D-AP5 and AM630 on memory consolidation deficit.

Conclusions

These results suggest that CA1 CB2 receptors modulate memory consolidation impairment induced by D-AP5.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ando RD, Biro J, Csolle C, Ledent C, Sperlagh B (2012) The inhibitory action of exo- and endocannabinoids on [(3)H]GABA release are mediated by both CB(1) and CB(2) receptors in the mouse hippocampus. Neurochem Int 60:145–152

    Article  CAS  PubMed  Google Scholar 

  • Aracil-Fernandez A, Trigo JM, Garcia-Gutierrez MS, Ortega-Alvaro A, Ternianov A, Navarro D, Robledo P, Berbel P, Maldonado R, Manzanares J (2012) Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB(2) receptors. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 37:1749–1763

    Article  CAS  Google Scholar 

  • Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160:467–479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barria A, Malinow R (2005) NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 48:289–301

    Article  CAS  PubMed  Google Scholar 

  • Brusco A, Tagliaferro P, Saez T, Onaivi ES (2008) Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62:944–949

    Article  CAS  PubMed  Google Scholar 

  • Cammarota M, Barros DM, Vianna MR, Bevilaqua LR, Coitinho A, Szapiro G, Izquierdo LA, Medina JH, Izquierdo I (2004) The transition from memory retrieval to extinction. Anais da Academia Brasileira de Ciencias 76:573–582

    Article  Google Scholar 

  • Cercato MC, Colettis N, Snitcofsky M, Aguirre AI, Kornisiuk EE, Baez MV, Jerusalinsky DA (2014) Hippocampal NMDA receptors and the previous experience effect on memory. J Physiol Paris 108:263–269

    Article  PubMed  Google Scholar 

  • Cheli V, Adrover M, Blanco C, Ferrari C, Cornea A, Pitossi F, Epstein AL, Jerusalinsky D (2006) Knocking-down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning. J Neurochem 97(Suppl 1):68–73

    Article  CAS  PubMed  Google Scholar 

  • Darbandi N, Rezayof A, Zarrindast MR (2008) Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area. Physiol Behav 94:604–610

    Article  CAS  PubMed  Google Scholar 

  • de Oliveira Alvares L, Genro BP, Vaz Breda R, Pedroso MF, Da Costa JC, Quillfeldt JA (2006) AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res 1075:60–67

    Article  PubMed  Google Scholar 

  • Demuth DG, Molleman A (2006) Cannabinoid signalling. Life Sci 78:549–563

    Article  CAS  PubMed  Google Scholar 

  • Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M (2007) Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28:39–45

    Article  CAS  PubMed  Google Scholar 

  • Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Berger TW (1999) 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol 81:925–929

    CAS  PubMed  Google Scholar 

  • Garcia-Gutierrez MS, Manzanares J (2011) Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. J Psychopharmacol 25:111–120

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Gutierrez MS, Ortega-Alvaro A, Busquets-Garcia A, Perez-Ortiz JM, Caltana L, Ricatti MJ, Brusco A, Maldonado R, Manzanares J (2013) Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology 73:388–396

    Article  CAS  PubMed  Google Scholar 

  • Ge Y, Dong Z, Bagot RC, Howland JG, Phillips AG, Wong TP, Wang YT (2010) Hippocampal long-term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci U S A 107:16697–16702

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ghersi MS, Gabach LA, Buteler F, Vilcaes AA, Schioth HB, Perez MF, de Barioglio SR (2015) Ghrelin increases memory consolidation through hippocampal mechanisms dependent on glutamate release and NR2B-subunits of the NMDA receptor. Psychopharmacology 232:1843–1857

    Article  CAS  PubMed  Google Scholar 

  • Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10–23

    Article  CAS  PubMed  Google Scholar 

  • Gu X, Mei F, Liu Y, Zhang R, Zhang J, Ma Z (2011) Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid. Anesth Analg 113:405–411

    Article  CAS  PubMed  Google Scholar 

  • Hampson RE, Miller F, Palchik G, Deadwyler SA (2011) Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 60:944–952

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hlinak Z, Krejci I (1995) Kynurenic acid and 5, 7-dichlorokynurenic acids improve social and object recognition in male rats. Psychopharmacology 120:463–469

    Article  CAS  PubMed  Google Scholar 

  • Jerusalinsky D, Ferreira MB, Walz R, Da Silva RC, Bianchin M, Ruschel AC, Zanatta MS, Medina JH, Izquierdo I (1992) Amnesia by post-training infusion of glutamate receptor antagonists into the amygdala, hippocampus, and entorhinal cortex. Behav Neural Biol 58:76–80

    Article  CAS  PubMed  Google Scholar 

  • Khella R, Short JL, Malone DT (2014) CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice. Psychopharmacology 231:3071–3087

    Article  CAS  PubMed  Google Scholar 

  • Kim J, Li Y (2015) Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J Physiol 593:871–886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Kim J (2015) Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus. Neuroscience 311:253–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liang KC, Hon W, Davis M (1994) Pre- and posttraining infusion of N-methyl-D-aspartate receptor antagonists into the amygdala impair memory in an inhibitory avoidance task. Behav Neurosci 108:241–253

    Article  CAS  PubMed  Google Scholar 

  • Lichtermann D, Karbe E, Maier W (2000) The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 250:304–310

    Article  CAS  PubMed  Google Scholar 

  • Lin QS, Yang Q, Liu DD, Sun Z, Dang H, Liang J, Wang YX, Chen J, Li ST (2011) Hippocampal endocannabinoids play an important role in induction of long-term potentiation and regulation of contextual fear memory formation. Brain Res Bull 86:139–145

    Article  CAS  PubMed  Google Scholar 

  • Morgan NH, Stanford IM, Woodhall GL (2009) Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 57:356–368

    Article  CAS  PubMed  Google Scholar 

  • Nasehi M, Amin-Yavari S, Ebrahimi-Ghiri M, Torabi-Nami M, Zarrindast MR (2015) The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in step-down passive avoidance learning task. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 25:557–565

    Article  CAS  Google Scholar 

  • Naseri MH, Hesami-Tackallou S, Torabi-Nami M, Zarrindast MR, Nasehi M (2014) Involvement of the CA1 GABAA receptors in MK-801-induced anxiolytic-like effects: an isobologram analysis. Behav Pharmacol 25:197–205

    Article  CAS  PubMed  Google Scholar 

  • Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514–536

    Article  CAS  PubMed  Google Scholar 

  • Ortega-Alvaro A, Aracil-Fernandez A, Garcia-Gutierrez MS, Navarrete F, Manzanares J (2011) Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 36:1489–1504

    Article  CAS  Google Scholar 

  • Packard MG, Teather LA (1997) Double dissociation of hippocampal and dorsal-striatal memory systems by posttraining intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav Neurosci 111:543–551

    Article  CAS  PubMed  Google Scholar 

  • Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates (6rd ed.). Academic Press, London

  • Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 12:1152–1158

    Article  CAS  PubMed  Google Scholar 

  • Puma C, Bizot JC (1998) Intraseptal infusions of a low dose of AP5, a NMDA receptor antagonist, improves memory in an object recognition task in rats. Neurosci Lett 248:183–186

    Article  CAS  PubMed  Google Scholar 

  • Quinn JJ, Loya F, Ma QD, Fanselow MS (2005) Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus 15:665–674

    Article  CAS  PubMed  Google Scholar 

  • Rasekhi K, Oryan S, Nasehi M, Zarrindast MR (2014) Involvement of the nucleus accumbens shell glutamatergic system in ACPA-induced impairment of inhibitory avoidance memory consolidation. Behav Brain Res 269:28–36

    Article  CAS  PubMed  Google Scholar 

  • Rubino T, Zamberletti E, Parolaro D (2015) Endocannabinoids and mental disorders. Handb Exp Pharmacol 231:261–283

    Article  PubMed  Google Scholar 

  • Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773–778

    Article  CAS  PubMed  Google Scholar 

  • Svizenska I, Dubovy P, Sulcova A (2008) Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review. Pharmacol Biochem Behav 90:501–511

    Article  CAS  PubMed  Google Scholar 

  • Tallarida RJ, Porreca F, Cowan A (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45:947–961

    Article  CAS  PubMed  Google Scholar 

  • Terranova JP, Michaud JC, Le Fur G, Soubrie P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 a, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedeberg's Arch Pharmacol 352:576–579

    Article  CAS  Google Scholar 

  • Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J (2004) Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46:966–973

    Article  CAS  PubMed  Google Scholar 

  • Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588–592

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Wu D, Xie C, Wang H, Wang W, Zhang H, Liu R, Xu LX, Mei XP (2013) Tramadol and propentofylline coadministration exerted synergistic effects on rat spinal nerve ligation-induced neuropathic pain. PLoS One 8:e72943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Authors wish to thank the Iran National Science Foundation (INSF) for providing financial support to this project.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mohammad Nasehi or Mohammad-Reza Zarrindast.

Additional information

Research highlights

• Intra-CA1 microinjection of D-AP5 impaired memory consolidation.

• Similar response was observed by activation or blockade of CB2Rs, dose-dependently.

• The lower dose of GP1a restored memory impairment induced by D-AP5.

• Subthreshold dose of AM630 modulated memory impairment induced by D-AP5.

• There is a synergistic effect between D-AP5 and AM630 on memory deficit.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nasehi, M., Hajikhani, M., Ebrahimi-Ghiri, M. et al. Interaction between NMDA and CB2 function in the dorsal hippocampus on memory consolidation impairment: an isobologram analysis. Psychopharmacology 234, 507–514 (2017). https://doi.org/10.1007/s00213-016-4481-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-016-4481-9

Keywords

Navigation